Literature DB >> 11039344

Choroid plexus changes after temporal lobectomy.

S Saluja1, N Sato, Y Kawamura, W Coughlin, C M Putman, D D Spencer, G Sze, R A Bronen.   

Abstract

BACKGROUND AND
PURPOSE: Postoperative contrast-enhanced MR imaging of the brain is routinely used when evaluating for residual or recurrent brain tumor. It is imperative to be aware of morphologic changes and imaging features that typically occur in response to surgical manipulation at the postoperative site to avoid misinterpretation of imaging findings. Our purpose was to determine normal postoperative changes and alterations in the choroid plexus among patients who had undergone temporal lobectomy in order to distinguish this appearance from pathologic changes that may be seen in the presence of infection or recurrent tumors.
METHODS: We reviewed 159 MR scans from 95 patients with hippocampal sclerosis or gliosis who underwent temporal lobectomy for treatment of intractable epilepsy. Choroid plexus location and size were assessed on contrast-enhanced T1-weighted images.
RESULTS: After temporal lobectomy, the choroid plexus enlarged and sagged into the resection site. Increase in the size of the choroid plexus occurred in 58% of cases overall. The degree of enhancement also increased after surgery, sometimes resulting in a nodular pattern of enhancement. The changes were most marked during the 1st week after temporal lobectomy, and showed an enlarged, markedly enhancing choroid plexus on 86% of the scans.
CONCLUSION: Postoperative changes of the choroid plexus after temporal lobectomy include sagging into the resection site, an increased size, and an increased degree of enhancement. Normal postoperative morphologic characteristics may mimic neoplastic enhancement pattern. Familiarity with this appearance is important to avoid a pitfall in diagnosis of recurrent postoperative temporal lobe neoplasms.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11039344      PMCID: PMC8174865     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  7 in total

1.  Postoperative changes in the brain: MR imaging findings in patients without neoplasms.

Authors:  N Sato; R A Bronen; G Sze; Y Kawamura; W Coughlin; C M Putman; D D Spencer
Journal:  Radiology       Date:  1997-09       Impact factor: 11.105

2.  Access to the posterior medial temporal lobe structures in the surgical treatment of temporal lobe epilepsy.

Authors:  D D Spencer; S S Spencer; R H Mattson; P D Williamson; R A Novelly
Journal:  Neurosurgery       Date:  1984-11       Impact factor: 4.654

3.  Postoperative CT contrast enhancement following lobectomy for epilepsy.

Authors:  V Laohaprasit; D L Silbergeld; G A Ojemann; J M Eskridge; H R Winn
Journal:  J Neurosurg       Date:  1990-09       Impact factor: 5.115

4.  Early postoperative magnetic resonance imaging after resection of malignant glioma: objective evaluation of residual tumor and its influence on regrowth and prognosis.

Authors:  F K Albert; M Forsting; K Sartor; H P Adams; S Kunze
Journal:  Neurosurgery       Date:  1994-01       Impact factor: 4.654

5.  Dyke Award. Evaluation of contrast-enhanced MR imaging in a brain-abscess model.

Authors:  V M Runge; J A Clanton; A C Price; W A Herzer; J H Allen; C L Partain; A E James
Journal:  AJNR Am J Neuroradiol       Date:  1985 Mar-Apr       Impact factor: 3.825

6.  Early postoperative magnetic resonance imaging following nonneoplastic cortical resection.

Authors:  M M Henegar; C J Moran; D L Silbergeld
Journal:  J Neurosurg       Date:  1996-02       Impact factor: 5.115

7.  Postoperative evaluation for intracranial recurrence of medulloblastoma: MR findings with gadopentetate dimeglumine.

Authors:  S P Meyers; S Wildenhain; M A Chess; R W Tarr
Journal:  AJNR Am J Neuroradiol       Date:  1994-09       Impact factor: 3.825

  7 in total
  1 in total

Review 1.  Imaging of Neuromodulation and Surgical Interventions for Epilepsy.

Authors:  M E Adin; D D Spencer; E Damisah; A Herlopian; J L Gerrard; R A Bronen
Journal:  AJNR Am J Neuroradiol       Date:  2021-08-05       Impact factor: 4.966

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.